Latest news
Medicus Pharma targets Gorlin Syndrome with SkinJect - ICYMI - Proactive financial newsProactive financial news · Sat, 01 Aug 2026 09:00:24 GMTPathos Communications confirmed a "very, very solid start" to its financial year - ICYMI - Proactive financial newsProactive financial news · Fri, 31 Jul 2026 15:57:38 GMTRivian reports higher revenue and improved profitability in Q2 as R2 deliveries begin - Proactive financial newsProactive financial news · Fri, 31 Jul 2026 10:56:00 GMTIlika CEO on FY26 highlights as Stereax sales begin and Goliath makes giant leaps - Proactive financial newsProactive financial news · Wed, 29 Jul 2026 11:51:14 GMTSmall Cap Watch: It's quarterly season as AuMEGA starts drilling and Aurum advances Boundiali gold project - Proactive financial newsProactive financial news · Mon, 27 Jul 2026 23:42:26 GMTMedicus Pharma cleared by FDA for registrational Phase 2b trial in patients with Gorlin Syndrome - Proactive financial newsProactive financial news · Mon, 27 Jul 2026 16:15:53 GMTFDA Recommends Two-Year Follow-Up for Gorlin Syndrome Study - Stock TitanStock Titan · Mon, 27 Jul 2026 12:17:00 GMTMedicus Pharma receives FDA clearance to begin registrational SkinJect study for Gorlin syndrome - Proactive financial newsProactive financial news · Mon, 27 Jul 2026 09:34:00 GMT